K Number
K111400
Device Name
OPTETRAK LOGIC CR TIBIAL INSERT, OPTETRAK LOGIC CR FEMORAL COMPONENT
Manufacturer
Date Cleared
2011-07-28

(70 days)

Product Code
Regulation Number
888.3560
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
The Optetrak Logic Total Knee System is indicated for use in skeletally mature individuals undergoing primary surgery for total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis, and/or post-traumatic degenerative problems. They are also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present. In the USA, the OPTETRAK Logic Total Knee System is indicated for cemented use only.
Device Description
Proposed Optetrak Logic CR Knee System femoral components are modifications to existing femoral components cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak Logic Total Knee System 510(k) #K093360. Proposed Optetrak Logic CR Knee System tibial inserts are modifications to existing tibial inserts cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak CR Slope 510(k) #K082022. The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities: - the same indications for use . - the same design features . - . the same materials - the same shelf life . - . packaging and sterilization using the same materials and processes - compatible with the same corresponding Optetrak tibial trays ● The Optetrak Logic CR Knee System is not being submitted as the result of a recall or any corrective action related to the Optetrak product lines.
More Information

No
The summary describes a traditional knee implant system and its modifications, with no mention of AI or ML technology in its design, function, or intended use.

Yes
The device is a total knee system used for replacement due to various medical conditions, indicating its therapeutic purpose in treating or alleviating these conditions.

No

Explanation: The device description and intended use clearly state that the Optetrak Logic Total Knee System is a surgical implant used for total knee replacement, not a device designed to diagnose medical conditions.

No

The device description clearly outlines physical components (femoral components, tibial inserts, tibial trays) made of specific materials, indicating it is a hardware-based medical device.

No, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
  • Device Description: The provided text describes the Optetrak Logic Total Knee System as a device used for total knee replacement surgery. This is a surgical implant, not a device used for testing biological samples.
  • Intended Use: The intended use clearly states it's for "primary surgery for total knee replacement" and "revision of failed previous reconstructions." This is a therapeutic and reconstructive purpose, not a diagnostic one.

The information provided describes a surgical implant used directly within the body, which falls under the category of medical devices, but specifically not In Vitro Diagnostics.

N/A

Intended Use / Indications for Use

The Optetrak Logic Total Knee System is indicated for use in skeletally mature individuals undergoing primary surgery for total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis, and/or post-traumatic degenerative problems. They are also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present.

In the USA, the OPTETRAK Logic Total Knee System is indicated for cemented use only.

Product codes

JWH

Device Description

Proposed Optetrak Logic CR Knee System femoral components are modifications to existing femoral components cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak Logic Total Knee System 510(k) #K093360.

Proposed Optetrak Logic CR Knee System tibial inserts are modifications to existing tibial inserts cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak CR Slope 510(k) #K082022.

The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities:

  • the same indications for use .
  • the same design features .
  • . the same materials
  • the same shelf life .
  • . packaging and sterilization using the same materials and processes
  • compatible with the same corresponding Optetrak tibial trays ●

The Optetrak Logic CR Knee System is not being submitted as the result of a recall or any corrective action related to the Optetrak product lines.

Mentions image processing

Not Found

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Not Found

Anatomical Site

Knee joint

Indicated Patient Age Range

Skeletally mature individuals

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Engineering studies were performed.

  • Logic CR insert/femoral component compatibility: Engineering drawing comparison to mating components and equivalent predicates
  • Logic CR insert/tibial tray compatibility: Engineering drawing comparison to mating components and equivalent predicates
  • Tibial insert scope addition mechanical properties: Engineering evaluation using Finite Element Analysis to compare contact stresses with predicates
  • Femoral component scope addition equivalency: Engineering drawing comparison to mating components and equivalent predicates
  • Femoral component design modification: Engineering evaluation using Finite Element Analysis to compare contact stresses with predicates

Key results: Results of engineering studies referenced in this 510(k) submission demonstrate proposed Optetrak Logic CR Knee System devices are substantially equivalent to cited cleared predicate devices.

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K932690, K093360, K082022

Reference Device(s)

Not Found

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 888.3560 Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis.

(a)
Identification. A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.

0

Exactech® Optetrak® Logic® CR Knee System Special 510(k) - 510(k) Summary of Safety and Effectiveness

JUL 2 8 2011

Exactech® Inc. Sponsor: 2320 N.W. 66th Court Gainesville, FL 32653

e, FL 32655

(352) 377-1140

Phone: (352) 377-1140 Fax: (352) 378-2617

FDA Establishment Number 1038671

  • Contact: Patrick Hughes Regulatory Affairs Specialist
    May 17, 2011 Date:

Trade or Proprietary or Model Name(s): Exactech® Optetrak® Logic® CR Knee System

Common Name: Cemented Total Knee Prosthesis

Classification Name:

21 CFR 888.3560 - Knee joint patellofemorotibial polymer semi-constrained cemented prosthesis.

Product Code: JWH - prosthesis, knee, patellofemorotibial, semi-constrained, cemented, polymer/metal/polymer

FDA Classification: Class II

Information on devices to which substantial equivalence is claimed:

510(k) NumberTrade or Proprietary or Model NameManufacturer
K932690Optetrak Cruciate Retaining Cemented Total Knee SystemExactech, Inc.
K093360Optetrak Logic Total Knee SystemExactech, Inc.
K082022Optetrak CR SlopeExactech, Inc.

: ', '

KIILOD

1

Exactech® Optetrak® Logic® CR Knee System Special 510(k) - 510(k) Summary of Safety and Effectiveness

Indications for Use:

The Optetrak Logic Total Knee System is indicated for use in skeletally mature individuals undergoing primary surgery for total knee replacement due to osteoarthritis, osteonecrosis, rheumatoid arthritis, and/or post-traumatic degenerative problems. They are also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present.

In the USA, the OPTETRAK Logic Total Knee System is indicated for cemented use only.

Device Description:

Proposed Optetrak Logic CR Knee System femoral components are modifications to existing femoral components cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak Logic Total Knee System 510(k) #K093360.

Proposed Optetrak Logic CR Knee System tibial inserts are modifications to existing tibial inserts cleared per Optetrak Cruciate Retaining Cemented Total Knee System 510(k) #K932690 and Optetrak CR Slope 510(k) #K082022.

The predicate and proposed devices have the same intended use and basic fundamental scientific technology and share the following similarities:

  • the same indications for use .
  • the same design features .
  • . the same materials
  • the same shelf life .
  • . packaging and sterilization using the same materials and processes
  • compatible with the same corresponding Optetrak tibial trays ●

The Optetrak Logic CR Knee System is not being submitted as the result of a recall or any corrective action related to the Optetrak product lines.

Performance Data

Table 1 shows performance data provided, cited, or referenced in this submission to support a conclusion of substantial equivalence:

EvaluationActivities Performed
Logic CR insert/femoral component
compatibilityEngineering drawing comparison to mating components and equivalent
predicates
Logic CR insert/tibial tray
compatibilityEngineering drawing comparison to mating components and equivalent
predicates
Tibial insert scope addition
mechanical propertiesEngineering evaluation using Finite Element Analysis to compare contact
stresses with predicates
Femoral component scope addition
equivalencyEngineering drawing comparison to mating components and equivalent
predicates
Femoral component design
modificationEngineering evaluation using Finite Element Analysis to compare contact
stresses with predicates

Table 1: Optetrak Logic CR Performance Data

2

Exactech® Optetrak® Logic® CR Knee System Special 510(k) - 510(k) Summary of Safety and Effectiveness

Substantial Equivalence Conclusion:

Results of engineering studies referenced in this 510(k) submission demonstrate proposed Optetrak Logic CR Knee System devices are substantially equivalent to cited cleared predicate devices.

KI|1400 Page 3 of 3

3

Image /page/3/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized symbol resembling an abstract human figure with three flowing lines, positioned to the right. Encircling the symbol is the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" in a circular arrangement.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002

Exactech, Inc. % Mr. Patrick Hughes Re1g4ulatory Affairs Specialist 2320 NW 66" Court Gainesville, Florida 32653

JUL 28 2011

Re: K111400

Trade/Device Name: Exactech® Optetrak® Logic® CR Knee System Regulation Number: 21 CFR 888.3560 Regulation Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: JWH Dated: July 18, 2011 Received: July 20, 2011

Dear Mr. Hughes:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21

4

Page 2 - Mr. Patrick Hughes

CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours,

Mark M. Milkerson

Mark N. Melkerson Director Division of Surgical, Orthopedic, and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

5

Exactech® Optetrak® Logic® CR Knee System Special 510(k) - Indications for Use

510(k) Number:K111400
-------------------------

Device Name: Exactech® Optetrak® Logic® CR Knee System

INDICATIONS

.

The OPTETRAK Logic Total Knee System is indicated for use in skeletally mature individuals undergoing primary surgery for total knee replacement due to osteoarthritis, osteonecrosis, theumatoid arthritis and/or post-traumatic degenerative problems. They are also indicated for revision of failed previous reconstructions where sufficient bone stock and soft tissue integrity are present.

In the USA, the OPTETRAK Logic Total Knee System is indicated for cemented use only.

Prescription Use X (Part 21 CFR 801 Subpart D) and/or

Over-The-Counter Use (21 CFR 807 Subpart C)

Please do not write below this line - use another page if needed.

Concurrence of CDRH, Office of Device Evaluation (ODE)

tor m. melkerson

(Division Sign Off) (Division Sign Off)
Division of Surgical, Orthopedic, Orthopedic, Devices Division ODSurgious, and Restorative Devices

510(k) Number R111400